Clinical Trials
3
Active:1
Completed:2
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants
Phase 1
Active, not recruiting
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Gasherbrum Bio, Inc
- Target Recruit Count
- 70
- Registration Number
- NCT06139055
- Locations
- 🇺🇸
ERG Clinical (Clinical Pharmacology of Miami - CPMI), Miami, Florida, United States
🇺🇸Syneos Miami Site, Miami, Florida, United States
🇺🇸Parexel Baltimore Early Phase Clinical Unit, Baltimore, Maryland, United States
A Study of Multiple Ascending Doses of GSBR-1290 in Japanese and Non-Japanese Healthy Participants
- First Posted Date
- 2023-06-07
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- Gasherbrum Bio, Inc
- Target Recruit Count
- 18
- Registration Number
- NCT05893043
- Locations
- 🇺🇸
ACT, Anaheim, California, United States
Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Type2 Diabetes MellitusOverweight or Obesity
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-03-09
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Gasherbrum Bio, Inc
- Target Recruit Count
- 142
- Registration Number
- NCT05762471
- Locations
- 🇺🇸
Anaheim Clinical Trials, Anaheim, California, United States
🇺🇸ProSciento, Inc, Chula Vista, California, United States
🇺🇸QPS Miami Research Associates, Miami, Florida, United States
News
No news found